🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Adding Latissimus Dorsi Myofascial Release to Scapular Proprioceptive Neuromuscular Facilitation on Pain, Disability, and Range of Motion in Adhesive Capsulitis

RecruitingNAAges 35 Years - 70 YearsAllIbadat International University, Islamabad
NCT07588087 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial aims to compare the effects of scapular proprioceptive neuromuscular facilitation (PNF) alone versus PNF combined with latissimus dorsi myofascial release on pain, range of motion, and functional disability in patients with stage II adhesive capsulitis; a condition characterized by capsular stiffness, pain, and restricted shoulder mobility, with outcomes assessed using NPRS, goniometry, and SPADI over a 6-week intervention period.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 1\. Age between 35 and 70 years. * Both male and female participants. * Stiffening (Stage II) phase of frozen shoulder. * Pain intensity ≥ 4/10 on NPRS during shoulder movement. * Unilateral shoulder involvement. * Presence of capsular pattern:ER \> ABD \> IR limitation * Apley's Scratch Test * Limited both ROMs * Symptom duration between 3 and 9 months.(Di Mascio et al., 2024) Exclusion Criteria: * Secondary adhesive capsulitis due to trauma or surgery * History of shoulder fracture or dislocation. * Bilateral frozen shoulder. * Active systemic inflammatory or neurological disease * Recent intra-articular corticosteroid injection (within last 3 months) * Current anticoagulation therapy or bleeding disorders. * Pregnant females.
💊

What it tests

  • Myofascial release+ Scapular Proprioceptive Neuromuscular Facilitation (PNF) hold-relax technique
  • Scapular PNF hold-relax only
📍

Where

1 site
• Ibadat international hospital • Shaafi international hospital • South East hospital • Fauji Foundation hospital
Islamabad, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy